Co-delivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for synergistic cancer treatmentJOURNAL OF CONTROLLED RELEASEIF11.52017-08-010PREAI
Lipid-polymer hybrid nanoparticles with aggregation-induced emission (AIE) characteristic for imaging-guided drug deliveryJOURNAL OF CONTROLLED RELEASEIF11.52017-08-010PREAI
Doxorubicin-conjugated magnetic iron oxide nanoparticles for pH-sensitive and magnetic responsive drug deliveryJOURNAL OF CONTROLLED RELEASEIF11.52015-09-0111PREAI
Lipid-polymer hybrid nanoparticles for the delivery of gemcitabineJOURNAL OF CONTROLLED RELEASEIF11.52015-09-014PREAI
Co-delivery of doxorubicin and amphiphilic derivative of Gd-DTPA with lipid-polymer hybrid nanoparticles for simultaneous imaging and targeted therapy of cancerJOURNAL OF CONTROLLED RELEASEIF11.52015-09-012PRE
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向